ConforMIS Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
BEDFORD, Mass., Nov. 03, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
ConforMIS Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
BEDFORD, Mass., Nov. 03, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
TESARO Announces Third-Quarter 2016 Operating Results
Nov 03, 2016 20:06 pm UTC| Business
Niraparib rolling NDA submission to FDA complete, MAA accepted for review by EMAPre-launch planning ongoing to support four potential product launches in 2017 across U.S. and EuropePositive Phase 3 NOVA trial results...
TESARO Announces Third-Quarter 2016 Operating Results
Nov 03, 2016 20:06 pm UTC| Business
Niraparib rolling NDA submission to FDA complete, MAA accepted for review by EMAPre-launch planning ongoing to support four potential product launches in 2017 across U.S. and EuropePositive Phase 3 NOVA trial results...
ePlus Reports Second Quarter and First Half Financial Results
Nov 03, 2016 20:06 pm UTC| Business
Second Quarter Fiscal Year 2017 Net sales increased 10.5% to $371.5 million; technology segment net sales increased 11.3% to $362.7 million.Adjusted gross billings of product and services increased 13.0% to $487.3...
ePlus Reports Second Quarter and First Half Financial Results
Nov 03, 2016 20:06 pm UTC| Business
Second Quarter Fiscal Year 2017 Net sales increased 10.5% to $371.5 million; technology segment net sales increased 11.3% to $362.7 million.Adjusted gross billings of product and services increased 13.0% to $487.3...
Five Prime Announces Third Quarter 2016 Results and Provides Business Update
Nov 03, 2016 20:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.